Vaccines
Healthcare workers and residents of long-term care facilities, about 24 million people, will receive the first Covid-19 vaccine as soon as this Monday, marking a significant milestone in the fight against the pandemic. Experts advising the CDC have recommended that the next group to receive the vaccine, perhaps in January,
Vaccines
The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) has recommended emergency use approval for Pfizer/BioNTech's COVID-19 vaccine, paving the way for its immunization in the US. This comes after a 90-year-old British woman became the first person outside of a trial setting to
Vaccines
The US government has declined Pfizer's offers for additional batches of its COVID-19 vaccine, citing a bet on multiple vaccine options. Pfizer's board member and former FDA commissioner, Dr. Scott Gottlieb, stated that the company may not be able to offer more shots to the nation
Vaccines
Facebook announced a new policy to remove posts sharing false claims about COVID-19 vaccines from its platform and Instagram, in an effort to combat the spread of misinformation about the virus. The move comes as two leading vaccine candidates from Pfizer and Moderna await approval for emergency use authorization from
Vaccines
Supermarket pharmacy staff and food industry workers will be among the first groups in the nation to receive COVID-19 vaccines, following health care personnel and long-term care facility residents in Phase 1a of U.S. coronavirus vaccination allocation. The Centers for Disease Control and Prevention's (CDC) Advisory Committee
Vaccines
Global stocks jumped on Tuesday, with the Dow Jones, S&P 500, and Nasdaq futures rising between 0.3% and 1% after President Donald Trump authorized President-elect Joe Biden's presidential transition process. Trump's move, while still a long way from conceding the election, has eased
Vaccines
Growing optimism over the development of a Covid-19 vaccine continues to drive global markets higher, with the Dow Jones Industrial Average recovering to pre-pandemic levels and the Japanese Nikkei Stock Average reaching its highest levels since the early 1990s. The pound and euro have also benefited from the surge, with
Vaccines
The National Institutes of Health (NIH) and Moderna, Inc. have announced that their joint Phase 3 trial of the mRNA-1273 vaccine candidate has produced promising results, with an interim analysis suggesting that the vaccine is safe and effective at preventing symptomatic COVID-19 in adults. The data, reviewed by an independent
Vaccines
Bhubaneswar, Nov 16 -- Hyderabad-based vaccines and pharmaceutical company Biological E Ltd (BE) has initiated clinical trials for its Covid-19 subunit vaccine candidate in the country after receiving approval from the Drugs Controller General of India (DGCI). The vaccine candidate is developed in collaboration with Dynavax Technologies Corporation and Baylor
Vaccines
PDS Biotechnology Corporation has announced the opening of its VERSATILE-002 Phase 2 clinical trial for the treatment of head and neck cancer that has returned or spread. In collaboration with Merck, the trial will evaluate the efficacy and safety of combining PDS0101, a Versamune-based immunotherapy targeting human papillomavirus (HPV)-associated
Vaccines
The Regulatory Affairs Professionals Society releases its daily regulatory news and intelligence briefing, Regulatory Reconnaissance, which covers key developments in the regulatory affairs space. The briefing summarizes various news stories related to the pharmaceutical and medical device industries, including trials, approvals, and updates on the COVID-19 pandemic. Notable news includes
COVID-19
Citi, a leading global bank, has been chosen by Gavi, the Vaccine Alliance, to serve as the financial advisor for the COVAX Facility, a global procurement mechanism for COVID-19 vaccines. COVAX is a multilateral initiative aimed at developing, manufacturing, and deploying COVID-19 vaccines on a fair and equitable basis. The
